Shotaro Uehara

1.7k total citations
129 papers, 1.5k citations indexed

About

Shotaro Uehara is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Shotaro Uehara has authored 129 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Pharmacology, 74 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Shotaro Uehara's work include Pharmacogenetics and Drug Metabolism (98 papers), Drug Transport and Resistance Mechanisms (74 papers) and Drug-Induced Hepatotoxicity and Protection (21 papers). Shotaro Uehara is often cited by papers focused on Pharmacogenetics and Drug Metabolism (98 papers), Drug Transport and Resistance Mechanisms (74 papers) and Drug-Induced Hepatotoxicity and Protection (21 papers). Shotaro Uehara collaborates with scholars based in Japan, United States and France. Shotaro Uehara's co-authors include Hiroshi Yamazaki, Yasuhiro Uno, Norie Murayama, Erika Sasaki, Takashi Inoue, Makiko Shimizu, Hiroshi Suemizu, Masahiro Utoh, Nao Yoneda and Yuichiro Higuchi and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Shotaro Uehara

124 papers receiving 1.5k citations

Peers

Shotaro Uehara
Shotaro Uehara
Citations per year, relative to Shotaro Uehara Shotaro Uehara (= 1×) peers Marcella Martignoni

Countries citing papers authored by Shotaro Uehara

Since Specialization
Citations

This map shows the geographic impact of Shotaro Uehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shotaro Uehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shotaro Uehara more than expected).

Fields of papers citing papers by Shotaro Uehara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shotaro Uehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shotaro Uehara. The network helps show where Shotaro Uehara may publish in the future.

Co-authorship network of co-authors of Shotaro Uehara

This figure shows the co-authorship network connecting the top 25 collaborators of Shotaro Uehara. A scholar is included among the top collaborators of Shotaro Uehara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shotaro Uehara. Shotaro Uehara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakano, Masataka, Masato Tomii, Yuichiro Higuchi, et al.. (2025). Switch/sucrose non-fermentable complex interacts with constitutive androstane receptor to regulate drug-metabolizing enzymes and transporters in the liver. Drug Metabolism and Disposition. 53(4). 100057–100057.
2.
Suzuki, Shugo, Min Gi, Noriyuki Miyoshi, et al.. (2024). Urinary bladder carcinogenic potential of 4,4′-methylenebis(2-chloroaniline) in humanized-liver mice. Toxicological Sciences. 202(2). 210–219. 1 indexed citations
3.
Vée, Marc Le, Shotaro Uehara, Agnès Jamin, et al.. (2023). Drug transporter expression and activity in cryopreserved human hepatocytes isolated from chimeric TK-NOG mice with humanized livers. Toxicology in Vitro. 90. 105592–105592. 5 indexed citations
5.
Vée, Marc Le, et al.. (2022). Contribution of Humanized Liver Chimeric Mice to the Study of Human Hepatic Drug Transporters: State of the Art and Perspectives. European Journal of Drug Metabolism and Pharmacokinetics. 47(5). 621–637. 9 indexed citations
6.
Uehara, Shotaro, Hiroshi Suemizu, & Hiroshi Yamazaki. (2022). Cytochrome P450s in chimeric mice with humanized liver. Advances in pharmacology. 95. 307–328. 1 indexed citations
7.
Uehara, Shotaro, Yasuhiro Uno, Makiko Shimizu, & Hiroshi Yamazaki. (2021). Cloning, sequence analysis, and tissue expression of marmoset paraoxonase 1. Drug Metabolism and Pharmacokinetics. 39. 100398–100398. 1 indexed citations
8.
Uno, Yasuhiro, Shotaro Uehara, Norie Murayama, Makiko Shimizu, & Hiroshi Yamazaki. (2020). Expression of functional sulfotransferases (SULT) 1A1, 1A3, 1B1, 1C2, 1E1, and 2A1 in common marmosets. Biochemical Pharmacology. 180. 114189–114189. 8 indexed citations
9.
Uno, Yasuhiro, et al.. (2020). Systematic characterization of glutathione S-transferases in common marmosets. Biochemical Pharmacology. 174. 113835–113835. 9 indexed citations
10.
Ogawa, Shinichiro, Makiko Shimizu, Yusuke Kamiya, et al.. (2020). Increased plasma concentrations of an antidyslipidemic drug pemafibrate co-administered with rifampicin or cyclosporine A in cynomolgus monkeys genotyped for the organic anion transporting polypeptide 1B1. Drug Metabolism and Pharmacokinetics. 35(4). 354–360. 8 indexed citations
11.
Uehara, Shotaro, et al.. (2018). Survey of Drug Oxidation Activities in Hepatic and Intestinal Microsomes of Individual Common Marmosets, a New Nonhuman Primate Animal Model. Current Drug Metabolism. 20(2). 103–113. 7 indexed citations
12.
Uehara, Shotaro, et al.. (2017). Molecular Cloning and Characterization of Marmoset Aldehyde Oxidase. Drug Metabolism and Disposition. 45(8). 883–886. 8 indexed citations
13.
Uehara, Shotaro, Yasuhiro Uno, Takashi Inoue, et al.. (2016). Strong Induction of Cytochrome P450 1A/3A, But not P450 2B, in Cultured Hepatocytes from Common Marmosets and Cynomolgus Monkeys by Typical Human P450 Inducing Agents. Drug Metabolism Letters. 10(4). 244–253. 13 indexed citations
14.
Uno, Yasuhiro, Shotaro Uehara, & Hiroshi Yamazaki. (2016). Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes. Biochemical Pharmacology. 121. 1–7. 65 indexed citations
15.
Uno, Yasuhiro, Shotaro Uehara, Sakae Kohara, et al.. (2015). CYP2D44 polymorphisms in cynomolgus and rhesus macaques. Molecular Biology Reports. 42(7). 1149–1155. 9 indexed citations
16.
Uehara, Shotaro, Takashi Inoue, Masahiro Utoh, et al.. (2015). Simultaneous pharmacokinetics evaluation of human cytochrome P450 probes, caffeine, warfarin, omeprazole, metoprolol and midazolam, in common marmosets (Callithrix jacchus). Xenobiotica. 46(2). 163–168. 23 indexed citations
17.
Uno, Yasuhiro, Shotaro Uehara, Masakiyo Hosokawa, & Teruko Imai. (2014). Systematic Identification and Characterization of Carboxylesterases in Cynomolgus Macaques. Drug Metabolism and Disposition. 42(12). 2002–2006. 14 indexed citations
18.
Uehara, Shotaro, Norie Murayama, Chika Nakamura, et al.. (2014). Immunochemical quantification of cynomolgus CYP2J2, CYP4A and CYP4F enzymes in liver and small intestine. Xenobiotica. 45(2). 124–130. 14 indexed citations
19.
Uno, Yasuhiro, Shotaro Uehara, Norie Murayama, & Hiroshi Yamazaki. (2010). CYP2G2, Pseudogenized in Human, Is Expressed in Nasal Mucosa of Cynomolgus Monkey and Encodes a Functional Drug-Metabolizing Enzyme. Drug Metabolism and Disposition. 39(4). 717–723. 13 indexed citations
20.
Uno, Yasuhiro, et al.. (2008). Sex-Related Differences in the Expression of mfGSTA2, a Novel GST Identified in Cynomolgus Monkey (Macaca fascicularis). Drug Metabolism and Disposition. 37(3). 453–456. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026